FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Amoxicillin Powder for Suspension
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Teva Pharmaceuticals (New 06/03/2019)

Company Contact Information:

Presentation Posting Date Related Information
125 mg/5 mL powder for suspension (NDCs 0093-4150-73, 0093-4150-79 and 0093-4150-80) 06/03/2019 This product discontinuation is a business related decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English